Exagen To Promote Diagnostic Services Of EndoChoice In US
Under the terms of agreement, EndoChoice’s gastroenterology-focused sales force will introduce Exagen’s gene expression tests for the diagnosis of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.